Cytokinetics Inc (CYTK)
Working capital turnover
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 7,530 | 7,815 | 9,952 | 95,246 | 91,781 | 141,206 | 139,967 | 56,649 | 58,061 | 9,383 | 45,819 | 46,569 | 47,834 | 47,611 | 14,609 | 16,776 | 20,245 | 23,344 | 29,275 | 29,730 |
Total current assets | US$ in thousands | 628,051 | 561,416 | 586,575 | 680,629 | 795,186 | 884,275 | 602,250 | 623,526 | 535,672 | 494,941 | 364,229 | 433,117 | 474,221 | 418,412 | 218,954 | 225,938 | 233,752 | 176,535 | 184,951 | 186,400 |
Total current liabilities | US$ in thousands | 102,678 | 77,723 | 65,617 | 75,220 | 84,617 | 76,496 | 66,843 | 66,847 | 71,860 | 80,868 | 61,766 | 35,930 | 31,199 | 27,573 | 22,696 | 20,741 | 26,023 | 21,517 | 21,959 | 26,277 |
Working capital turnover | 0.01 | 0.02 | 0.02 | 0.16 | 0.13 | 0.17 | 0.26 | 0.10 | 0.13 | 0.02 | 0.15 | 0.12 | 0.11 | 0.12 | 0.07 | 0.08 | 0.10 | 0.15 | 0.18 | 0.19 |
December 31, 2023 calculation
Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $7,530K ÷ ($628,051K – $102,678K)
= 0.01
Working capital turnover is a financial ratio that measures a company's efficiency in generating revenue relative to its working capital. A higher working capital turnover indicates that the company is effectively utilizing its resources to drive sales.
From the data provided for Cytokinetics Inc, we observe fluctuations in the working capital turnover over the past eight quarters. The working capital turnover ratio has ranged from as low as 0.01 in Q4 2023 to as high as 0.28 in Q2 2022.
A low working capital turnover ratio, such as 0.01 in Q4 2023, suggests that the company may be inefficient in using its working capital to generate sales revenue during that period. On the other hand, a high ratio like 0.28 in Q2 2022 indicates that Cytokinetics Inc was able to generate a significant amount of revenue relative to its working capital investment.
It is important for the company to closely monitor its working capital turnover ratio to ensure efficient utilization of resources and maintain a balance between liquidity and operational efficiency. Analyzing trends in this ratio can provide insights into the company's financial performance and efficiency in managing its working capital over time.
Peer comparison
Dec 31, 2023